Related content

Risk factors for recurrence after transarterial chemoembolization for early-stage hepatocellular carcinoma

By Kinugasa Hideaki  

Journal of Gastroenterology, Vol. 47, Iss. 4, 2012-04 ,pp. : 421-426

Springer Publishing Company

Access to resources Recommend Favorite

Outcome of supraselective transarterial chemoembolization in patients with hepatocellular carcinoma

By Heinzow Hauke Sebastian   Meister Tobias   Nass Dominik   Kööhler Michael   Spieker Tilmann   Wolters Heiner   Domschke Wolfram   Domagk Dirk  

Scandinavian Journal of Gastroenterology, Vol. 46, Iss. 2, 2011-02 ,pp. : 201-210

Informa Healthcare

Access to resources Recommend Favorite

Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization

By Kim Jeong Han   Kim Ji Hoon   Choi Jong Hwan   Kim Chung Ho   Jung Young Kul   Yim Hyung Joon   Yeon Jong Eun   Park Jong-Jae   Kim Jae Seon   Bak Young-Tae   Byun Kwan Soo  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 3, 2009-03 ,pp. : 346-357

Informa Healthcare

Access to resources Recommend Favorite

Erratum to: Risk factors for recurrence after transarterial chemoembolization for early-stage hepatocellular carcinoma

By Kinugasa Hideaki  

Journal of Gastroenterology, Vol. 47, Iss. 4, 2012-04 ,pp. : 489-489

Springer Publishing Company

Access to resources Recommend Favorite

Safety of transarterial chemoembolization plus sorafenib combination treatment in unresectable hepatocellular carcinoma

By Sinakos Emmanouil   Dedes Ioannis   Papalavrentios Lavrentis   Drevelegas Antonios   Akriviadis Evangelos  

Scandinavian Journal of Gastroenterology, Vol. 45, Iss. 4, 2010-04 ,pp. : 511-512

Informa Healthcare

Access to resources Recommend Favorite